(11-372) Utilization of Ceftolozane/tazobactam (Zerbaxa®) and Ceftazidime/avibactam (Avycaz®) in Accordance with Antimicrobial Restriction Criteria

Wednesday, December 10, 2025

12:30 PM - 1:30 PM

Location: Bayside A, Level 1

Residency Program: Mount Sinai Morningside and Mount Sinai West
Residency Program Type: PGY1 (Pharmacy)
Residency Program Location: New York

Co-Author(s): Nicole Ondrush, Brittany Jackson, Daniel Mesa

Primary Author(s)

Alicia C. Zhang, PharmD